BioTie Therapies
Dr. Pauli Ollikka
-
Turku, Finland
BioTie Therapies (6, BIOTIE) is a biotechnology company which develops pharmaceutical products based on proprietary technology. It is co-developing “bioheparin” as an antithrombotic drug, and is involved in the development of antiangiogenic molecules derived from bacterial polysaccharide K5. It has facilities and experience for tumor growth inhibition studies.